COVID-19 antibody testing plays a critical role in the public health response to this pandemic, including helping to determine prevalence of SARS-CoV-2 infection in the community or population of interest, providing information to assist in surveillance program efforts and implement disease mitigation.
During this presentation
the presenters will discuss commercial lab and public health collaborations, including current COVID-19 initiatives, explain the basis for serology tests for COVID-19 and recommendations for use, and describe the utility of antibody testing in seroprevalence surveillance.
PACE® credits will not be available for this presentation.
Jay G. Wohlgemuth, MD
Chief Medical Officer
Senior Vice President, Research & Development and Medical
Quest Diagnostics, San Juan Capistrano, California
Hema Kapoor, MD, D (ABMM), SM
Senior Medical Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics, Secaucus, New Jersey
William A. Meyer III, PhD, D(ABMM), MLS (ASCP)CM
Director, Medical Science Liaison, Infectious Diseases/Immunology
Technical Director- Quest Diagnostics, East Region